Dipl.-Ing. Dr. Thomas Mohr
1 - 17 von 17
Hagn, G., Cho, A., Zila, N., Sterniczky, B., Jantschitsch, C., Dong, D., Bileck, A., Koren, M., Paulitschke, P., Mohr, T., Knobler, R., Weninger, W. P., Gerner, C., & Paulitschke, V. (2025). Extracorporeal photopheresis induces the release of anti-inflammatory fatty acids and oxylipins and suppresses pro-inflammatory sphingosine-1-phosphate. Inflammation Research, 74(1), Artikel 40. https://doi.org/10.1007/s00011-025-02007-6



Wimmer, B., Schernthaner, J., Edobor, G., Friedrich, A., Poeltner, K., Temaj, G., Wimmer, M., Kronsteiner, E., Pichler, M., Gercke, H., Huber, R., Kaefer, N., Rinnerthaler, M., Karl, T., Krauß, J., Mohr, T., Gerner, C., Hintner, H., Breitenbach, M., ... Breitenbach-Koller, H. (2024). RiboScreenTM Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin. International Journal of Molecular Sciences, 25(15), Artikel 8430. https://doi.org/10.3390/ijms25158430



Zila, N., Eichhoff, O. M., Steiner, I., Mohr, T., Bileck, A., Cheng, P. F., Leitner, A., Gillet, L., Sajic, T., Goetze, S., Friedrich, B., Janker-Bortel, P., Strobl, J., Reitermaier, R., Hogan, S. A., Martínez Gómez, J. M., Staeger, R., Tuchmann, F., Peters, S., ... Paulitschke, V. (2024). Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy. Clinical Cancer Research, 30(1), 159-175. https://doi.org/10.1158/1078-0432.CCR-23-0562


Baier, D., Mendrina, T., Schoenhacker-Alte, B., Pirker, C., Mohr, T., Rusz, M., Regner, B., Schaier, M., Sgarioto, N., Raynal, N. J. M., Nowikovsky, K., Schmidt, W. M., Heffeter, P., Meier-Menches, S. M., Koellensperger, G., Keppler, B. K., & Berger, W. (2023). The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone Acetylation. Advanced science, 10(32), Artikel 2301939. https://doi.org/10.1002/advs.202301939

Mödl, B., Awad, M., Zwolanek, D., Scharf, I., Schwertner, K., Milovanovic, D., Moser, D., Schmidt, K., Pjevac, P., Hausmann, B., Krauß, D., Mohr, T., Svinka, J., Kenner, L., Casanova, E., Timelthaler, G., Sibilia, M., Krieger, S., & Eferl, R. (2023). Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease. EMBO Reports, 24(10), Artikel e57084. https://doi.org/10.15252/embr.202357084

Janker, L., Schuster, D., Bortel, P., Hagn, G., Meier-Menches, S. M., Mohr, T., Mader, J. C., Slany, A., Bileck, A., Brunmair, J., Madl, C., Unger, L., Hennlich, B., Weitmayr, B., Del Favero, G., Pils, D., Pukrop, T., Pfisterer, N., Feichtenschlager, T., & Gerner, C. (2023). Multi-omics empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states. Journal of Crohn's & colitis, 17(9), 1514-1527. https://doi.org/10.1093/ecco-jcc/jjad052

Ries, A., Slany, A., Pirker, C., Mader, J. C., Mejri, D., Mohr, T., Schelch, K., Flehberger, D., Maach, N., Hashim, M., Hoda, M. A., Dome, B., Krupitza, G., Berger, W., Gerner, C., Holzmann, K., & Grusch, M. (2023). Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. Cells, 12(15), Artikel 2006. https://doi.org/10.3390/cells12152006

Caban, M., Koblmueller, B., Groza, D., Schueffl, H. H., Terenzi, A., Tolios, A., Mohr, T., Mathuber, M., Kryeziu, K., Jaunecker, C., Pirker, C., Keppler, B. K., Berger, W., Kowol, C. R., & Heffeter, P. (2023). A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo. Cancer Letters, 565, Artikel 216237. https://doi.org/10.1016/j.canlet.2023.216237



Malik, B., Vokic, I., Mohr, T., Poppelaars, M., Holcmann, M., Novoszel, P., Timelthaler, G., Lendl, T., Krauss, D., Elling, U., Mildner, M., Penninger, J. M., Petzelbauer, P., Sibilia, M., & Csiszar, A. (2023). FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice. EMBO Molecular Medicine, 15(7), Artikel e16758. https://doi.org/10.15252/emmm.202216758

Moritsch, S., Moedl, B., Scharf, I., Janker, L., Zwolanek, D., Timelthaler, G., Casanova, E., Sibilia, M., Mohr, T., Kenner, L., Herndler-Brandstetter, D., Gerner, C., Mueller, M., Strobl, B., & Eferl, R. (2022). Tyk2 is a tumor suppressor in colorectal cancer. OncoImmunology, 11(1), Artikel 2127271. https://doi.org/10.1080/2162402X.2022.2127271

1 - 17 von 17

Multi-Omics Data of Perturbation Studies are Determined by Memory Effects from Sub-culture

Patricia Bortel (Vortragende*r), Gerhard Hagn (Autor*in), Lukas Skos (Autor*in), Andrea Bileck (Autor*in), Verena Paulitschke (Autor*in), Philipp Paulitschke (Autor*in), Lion Gleiter (Autor*in), Thomas Mohr (Autor*in), Christopher Gerner (Autor*in) & Samuel Matthias Meier-Menches (Autor*in)

21 Feb. 2024

Aktivität: VorträgeVortragScience to Science


Multi-Omics Data of Perturbation Studies are Determined by Memory Effects from Sub-culture

Patricia Bortel (Vortragende*r), Gerhard Hagn (Autor*in), Lukas Skos (Autor*in), Andrea Bileck (Autor*in), Verena Paulitschke (Autor*in), Philipp Paulitschke (Autor*in), Lion Gleiter (Autor*in), Thomas Mohr (Autor*in), Christopher Gerner (Autor*in) & Samuel Matthias Meier-Menches (Autor*in)

27 Sept. 2023

Aktivität: VorträgeVortragScience to Science


Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets

Gerhard Hagn (Vortragende*r), Samuel Matthias Meier-Menches (Autor*in), Günter Plessl-Walder (Autor*in), Gaurav Mitra (Autor*in), Thomas Mohr (Autor*in), Karin Preindl (Autor*in), Andreas Schlatter (Autor*in), Doreen Schmidl (Autor*in), Christopher Gerner (Autor*in), Gerhard Garhöfer (Autor*in) & Andrea Bileck (Autor*in)

27 Sept. 2023

Aktivität: VorträgeVortragScience to Science


Multi-Omics Readouts of Perturbation Studies are Determined by Memory Effects from Subculture

Lukas Skos (Vortragende*r), Patricia Bortel (Autor*in), Gerhard Hagn (Autor*in), Andrea Bileck (Autor*in), Verena Paulitschke (Autor*in), Philipp Paulitschke (Autor*in), Lion Gleiter (Autor*in), Thomas Mohr (Autor*in), Christopher Gerner (Autor*in) & Samuel Matthias Meier-Menches (Autor*in)

11 Mai 2023

Aktivität: VorträgeVortragScience to Science


Institut für Analytische Chemie

Währinger Straße 38
1090 Wien

thomas.mohr@univie.ac.at